Alcoholic cardiomyopathy: The result of dosage and individual predisposition;Alkoholische Kardiomyopathie: Eine Folge der Dosis und der individuellen Prädisposition

Herz

Volumn 41, Issue 6, 2016, Pages 484-493

  Maisch, B ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Atrial fibrillation; Beriberi; Cirrhotic cardiomyopathy; Hypertension; Myocarditis

Indexed keywords

ACAMPROSATE; ANTICOAGULANT AGENT; ARSENIC; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; COBALT; DIAZEPAM; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DISULFIRAM; DIURETIC AGENT; NALMEFENE; NALTREXONE; ALCOHOL;

ABNORMAL LABORATORY RESULT; ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOLIC BEVERAGE; ALCOHOLIC CARDIOMYOPATHY; ALCOHOLISM; ARSENIC IN BEER; ARTICLE; ATHEROSCLEROSIS; BEER DRINKER DISEASE; BERIBERI HEART DISEASE; CARDIAC CIRRHOSIS; CARDIOMYOPATHY; CEREBROVASCULAR ACCIDENT; CIRRHOTIC CARDIOMYOPATHY; CLINICAL EXAMINATION; CORONARY ARTERY DISEASE; CYTOTOXICITY; DISEASE PREDISPOSITION; FOOD POISONING; HEART ARRHYTHMIA; HEART DISEASE; HEART FAILURE; HUMAN; HYPERTENSION; MYOCARDITIS; NONHUMAN; PROGNOSIS; RISK; SIGNAL TRANSDUCTION; SYMPTOMATOLOGY; CARDIAC MUSCLE; CARDIOMYOPATHY, ALCOHOLIC; DOSE RESPONSE; DRUG EFFECTS; HEART; IMMUNOLOGY; RISK FACTOR;

CARDIOMYOPATHY, ALCOHOLIC; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; HEART; HUMANS; MYOCARDIUM; RISK FACTORS;

EID: 84984846326     PISSN: 03409937     EISSN: 16156692     Source Type: Journal    
DOI: 10.1007/s00059-016-4469-6     Document Type: Article

References (131)

1. Madden JS (1993) The definition of alcoholism. Alcohol 28:617–620
2. Schuckit MA, Hesselbrock V, Tipp J et al (1994) A comparison of DSM-III-R, DSM-IV and ICD-10 substance use disorders diagnoses in 1922 men and women subjects in the COGA study. Addiction 89:1629–1638
3. Hasin D, McCloud S, Li Q, Endicott J (1996) Cross-system agreement among demographic subgroups: DSM-III, DSM-III-R, DSM-IV and ICD-10 diagnoses of alcohol use disorders. Drug Alcohol Depend 41:127–135
4. Preedy VR, Atkinson LM, Richardson PJ, Peters TJ (1993) Mechanisms of ethanol-induced cardiac damage. Br Heart J 69:197–200
5. Batra A, Müller CA, Mann K, Heinz A (2016) Abhängigkeit und schädlicher Gebrauch von Alkohol. Dtsch Arztebl 113:301–310
6. Mann K, Hoch E, Batra A (2015) S3-Leitlinie Screening, Diagnose und Behandlung alkoholbezogener Störungen. Springer, Heidelberg
7. Wodarz N, Mann K, Hoch E et al (2016) S3 Leitlinie: Alkoholbezogene Störungen, Screening, Diagnose und Behandlung. Bayerisches Ärztebl 2016(4):144–149
8. Connor JP, Huber PS, Hall WD (2016) Alcohol use disorders. Lancet 387:988–998
9. Rocco A, Compare D, Angrisani D et al (2014) Alcoholic disease: Liver and beyond. World J Gastroenterol 20:14652–14659
10. Solfrizzi V, D‘Introno A, Colacicco AM et al (2007) Alcohol consumption, mild cognitive impairment, and progression to dementia. Neurology 68(21):1790–1799
11. Panza F, Capurso C, D’Introno A et al (2009) Alcohol drinking, cognitive functions in older age, predementia, and dementia syndromes. J Alzheimers Dis 17(1):7–31
12. Gonçalves A, Claggett B, Jhund PS, Rosamond W (2015) Alcohol consumption and risk of heart failure: The Atherosclerosis Risk in Communities study. Eur Heart J 36:939–945
13. Goncalves A, Jhund PS, Glaggett B et al (2015) Relationship between alcohol consumption and cardiac structure and function in the elderly. The atherosclerosis risk in communities study. Circ Cardiovasc Imaging 8:e002846. doi:10.1161/CIRCIMAGING.114.002846
14. George A, Figueredo VM (2011) Alcoholic cardiomyopathy: A review. J Cardiac Fail 17:844–849
15. Maisch B (1996) Alcohol and the heart. Herz 21:207–212
16. Wilke A, Kaiser A, Ferency I, Maisch B (1996) Alcohol and myocarditis. Herz 21:248–257
17. Menz V, Grimm W, Hoffmann J, Maisch B (1996) Alcohol and rhythm disturbance: The Holiday Heart syndrome. Herz 21:227–231
18. Rupp H, Brilla CG, Maisch B (1996) Hypertension and alcohol: Central and peripheral mechanisms. Herz 21:258–264
19. Schoppet M, Maisch B (2001) Alcohol and the heart. Herz 26:345–352
20. Maisch B, Gelbrich G, Pankuweit S et al (2008) Alcohol and heart failure. Eur Heart J 29(Abstr Suppl):553
21. Münzinger (1877) Das Tübinger Herz. Ein Beitrag zur Lehre von der Überanstrengung des Herzens. Dtsch Arch Klin Med 19:449
22. Frenzel H, Schwartzkopff B (2000) Toxische Schäden des Herzens durch Alkohol, Anthrazykline und Kokain. In: Hort W (ed) Pathologie des Endokard, der Kranzarterien und des Myokard, 1st edn. vol 22/2. Springer, Berlin, pp 1175–1228
23. von Bollinger O (1884) Über die Häufigkeit und Ursachen der idiopathischen Herzhypertrophie in München. Dtsch Med Wochenschr 10:180
24. https://www.hdbg.eu. Accessed 8 Aug 2016
25. Steell G (1893) Heart failure as a result of chronic alcoholism. Med Chron Manchester 18:1–22
26. MacKenzie J (1902) The Study of the Pulse. Y. J. Pentland, Edinburgh, p 237
27. Brigden W, Robinson J (1964) Alcoholic heart disease. Brit Med J 2:1283–1289
28. Aalsmeer WC, Wenckebach KF (1929) Herz und Kreislauf bei der Beri Beri Krankheit. Wien Arch Inn Med 16:193–272
29. Akbarian M, Yankopoulos NA, Abelmann WH (1966) Hemodynamic studies in Beriberi heart disease. Am J Med 414(2):197–212
30. Djoenaidi W, Notermans SL, Dunda G (1992) Beriberi cardiomyopathy. Eur J Clin Nutr 46:227–234
31. Mehta PA, Dubrey SW (2009) High output failure. Q J Med 102:235–241
32. Hunt SA, Abraham WT, Chin MH et al (2005) ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult-summary article a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 46:1116–1143
33. Kelynack TN, Kirkby W (1901) Arsenical poisoning in beer drinkers. Baillière, Tyndall & Cox, London
34. Royal Commission Appointed to Inquire into Arsenical Poisoning from the Consumption of Beer and other Articles of Food or Drink (1903) ”Final Report“ Part I. Wyman and Sons, London
35. Reynolds ES (1901) An account of the epidemic outbreak of arsenical poisoning occurring in beer drinkers in the north of England and the midland counties in 1900. Lancet 157(4038):166–170
36. http://www.npr.org/sections/thesalt/2013/04/08/176587506/arsenic-in-beer-may-come-from-widely-used-filtering-process. Accessed 8 Aug 2016
37. McDermott PH, Delaney RL, Egan JD, Sullivan JF (1966) Myocardosis and cardiac failure in men. JAMA 198(3):253–256
38. Kesteloot H, Terryn R, Bosmans P, Joossens JV (1966) Alcoholic perimyocardiopathy. Acta Cardiol 21(3):341–357
39. Morin Y, Daniel P (1967) Quebec beer-drinkers‘ cardiomyopathy: Etiologic considerations. Can Med Assoc J 97:926–928
40. Bonenfant JL, Miller G, Roy PE (1967) Quebec beer-drinkers’ cardiomyopathy: pathologic studies. Can Med Assoc J 97:910–916
41. Sandusky GE, Henk WG, Roberts ED (1981) Histochemistry and ultrastructure of the heart in experimental cobalt cardiomyopathy in the dog. Toxicol Appl Pharmacol 61:89–95
42. Van Vleet JF, Rebar AH, Ferrans VJ (1977) Acute cobalt and isoproterenol cardiotoxicity in swine: Protection by selenium-vitamin E supplementation and potentiation by stress-susceptible phenotype. Am J Vet Res 38:991–1002
43. Dahms K, Sharkowva Y, Heitland P et al (2014) Cobalt intoxication diagnosed with the help of Dr House. Lancet 383:574
44. Møller S, Henriksen JH (2010) Cirrhotic cardiomyopathy. J Hepatol 53:179–190
45. Lian C (1915) L‘alcoholisme cause d’hypertension arterielle. Bull Acad Med 74:525–528
46. Abe H, Kawano Y, Kojima S et al (1994) Biphasic effects of repeated alcohol intake on 24-hour blood pressure in hypertensive patients. Circulation 89:2626–2633
47. Wigle DA, Pang SC, Sarda IR, a (1993) Acute ethanol ingestion modifies the circulating plasma levels of atrial natriuretic peptide. Alcohol 10:275–280
48. Guillaume P, Jankowski M, Gianoulakis C, Gutkowska J (1996) Effect of chronic ethanol consumption on the atrial natriuretic system of spontaneously hypertensive rats. Alcohol Clin Exp Res 20:1653–1661
49. Potter JF, Beevers DG (1984) Pressor effect of alcohol in hypertension. Lancet 1:119–122
50. MacMahon S (1987) Alcohol consumption and hypertension. Hypertension 9:111–121
51. Klatsky AL (1996) Alcohol and hypertension. Clin Chim Acta 246:91–105
52. Klatsky AL (2000) Alcohol and hypertension. In: Operil S, Weber M (eds) Hypertension, 2nd edn. WB. Saunders Co, Philadelphia, pp 211–220
53. Urbano-Marquez A, Estrich R, Navarro-Lopez F et al (1989) The effects of alcoholism on skeletal and cardiac muscle. N Engl J Med 320:409–415
54. Wendt VE, Ajluni R, Bruce TA et al (1966) Acute effects of alcohol on the human myocardium. Am J Cardiol 17:804–812
55. Regan TJ, Levinson GE, Oldewurtel HA (1969) Ventricular function in noncardiacs with alcoholic fatty liver: Role of ethanol in the production of cardiomyopathy. J Clin Invest 48:397–407
56. Burch GE, Giles TD (1971) Alcoholic cardiomyopathy. Concept of the disease and its treatment. Am J Med 50:141–145
57. McDonald CD, Burch GE, Walsh JJ (1971) Alcoholic cardiomyopathy managed with prolonged bed rest. Ann Intern Med 74:681–691
58. Richardson P, McKenna W, Bristow M et al (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 93:841–842
59. Regan TJ (1990) Alcohol and the cardiovascular system. JAMA 264:377–381
60. Rubin E, Urbano-Marquez A (1994) Alcoholic cardiomyopathy. Alcohol Clin Exp Res 18:111–114
61. Piano MR, Schwertz DW (1994) Alcoholic heart disease: A review. Heart Lung 23:3–17
62. Henry WL, Gardin JM, Ware JH (1980) Echocardiographic measurements in normal subjects from infancy to old age. Circulation 62:1054–1061
63. Kupari M, Koskinen P, Suokas A (1991) Left ventricular size, mass and function in relation to the duration and quantity of heavy drinking in alcoholics. Am J Cardiol 67:274–279
64. Fabrizio L, Regan TF (1994) Alcoholic cardiomyopathy. Cardiovasc Drugs Ther 8:89–94
65. Steinberg JD, Hayden MT (1981) Prevalence of clinically occult cardiomyopathy in chronic alcoholism. Am Heart J 101:461–464
66. Fernandez-Sola J, Estruch R, Grau JM et al (1994) The relation of alcoholic myopathy to cardiomyopathy. Ann Intern Med 120:529–536
67. Guarnieri T, Lakatta EG (1990) Mechanism of myocardial contractile depression by clinical concentrations of ethanol. A study in ferret papillary muscles. J Clin Invest 85:1462–1467
68. Danziger RS, Sakai M, Capogrossi MC et al (1991) Ethanol acutely and reversibly suppresses excitationcontraction coupling in cardiac myocytes. Circ Res 68:1660–1668
69. Thomas AP, Rozanski DJ, Renard DC, Rubin E (1994) Effects of ethanol on the contractile function of the heart: A review. Alcohol Clin Exp Res 18:121–131
70. Kojima S, Wu ST, Wikman-Coffelt J, Parmley WW (1993) Acute effects of ethanol on cardiac function and intracellular calcium in perfused rat heart. Cardiovasc Res 27:811–816
71. Tepper D, Capasso JM, Sonnenblick EH (1986) Excitation-contraction coupling in rat myocardium: Alterations with long term ethanol consumption. Cardiovasc Res 20:369–374
72. Das AM, Harris DA (1993) Regulation of the mitochondrial ATP-synthase is defective in rat heart during alcohol-induced cardiomyopathy. Biochim Biophys Acta 1181:295–299
73. Capasso JM, Li P, Guideri G et al (1992) Myocardial mechanical, biochemical, and structural alterations induced by chronic ethanol ingestion in rats. Circ Res 71:346–356
74. Segel LD, Rendig SV, Choquet Y et al (1975) Effects of chronic graded ethanol consumption on the metabolism, ultrastructure, and mechanical function of the rat heart. Cardiovasc Res 9:649–663
75. Siddiq T, Richardson PJ, Mitchell WD et al (1993) Ethanolinduced inhibition of ventricular protein synthesis in vivo and the possible role of acetaldehyde. Cell Biochem Funct 11:45–54
76. Preedy VR, Peters PJ (1990) Changes in protein, RNA, and DNA and rates of protein synthesis in muscle-containing tissues of the mature rat in response to ethanol feeding: A comparative study of heart, small intestine and gastrocnemius muscle. Alcohol Alcohol 25:489–498
77. Lang CH, Frost RA, Kumar V, Vary T (2000) Impaired myocardial protein synthesis induced by acute alcohol intoxication is associated with changes in eIF4F. Am J Physiol Endocrinol Metab 279:1029–1038
78. Preedy VR, Patel VB, Why HJ et al (1996) Alcohol and the heart: Biochemical alterations. Cardiovasc Res 31:139–147
79. Patel VB, Sandhu G, Corbett JM et al (2000) A comparative investigation into the effect of chronic alcohol feeding on the myocardium of normotensive and hypertensive rats: An electrophoretic and biochemical study. Electrophoresis 21:2454–2462
80. Chen DB, Wang L, Wang PH (2000) Insulin-like growth factor I retards apoptotic signaling induced by ethanol in cardiomyocytes. Life Sci 67:1683–1693
81. Fernández-Solà J, Fatjó F, Sacanella E et al (2006) Evidence of apoptosis in alcoholic cardiomyopathy. Hum Pathol 37(8):1100–1110
82. Hajnoczky G, Buzas CJ, Pacher P et al (2005) Alcohol and mitochondria in cardiac apoptosis: Mechanisms and visualization. Alcohol Clin Exp Res 29:693–701
83. Rodriguez A, Chawla K, Umoh NA et al (2015) Alcohol and apoptosis: Friends or foes? Biomolecules 5:3193–3203
84. Vasiljevic JD, Kanjuh V, Seferovic P et al (1990) The incidence of myocarditis in endomyocardial biopsy samples from patients with congestive heart failure. Am Heart J 120:1370–1377
85. Morin Y, Roy PE, Mohiuddin SM, Taskar PK (1969) The influence of alcohol on viral and isoproterenol cardiomyopathy. Cardiovasc Res 3(3):363–368
86. Bernstein IM, Webster KH, Williams RC, Strickland RG (1974) Reduction in circulating T lymphocytes in alcoholic liver disease. Lancet 2:488–490
87. Arbabi S, Garcia I, Bauer GJ, Maier RV (1999) Alcohol (ethanol) inhibits IL-8 and TNF: role of the p38 pathway. J Immunol 162:7441–7445
88. Cook RT (1998) Alcohol abuse, alcoholism, and damage to the immune system – a review. Alcohol Clin Exp Res 22:1927–1942
89. Heberden W (1786) Some account of a disorder of the breast. Med Trans R Coll Physicians (london) 2:59–67
90. Klatsky AL, Friedman GD, Siegelaub AB (1974) Alcohol consumption before myocardial infarction. Results from the Kaiser-Permanente epidemiologic study of myocardial infarction. Ann Intern Med 81:294–301
91. Black S (1819) Clinical and pathological reports. Alex Wilkinson, Newry, pp 1–47
92. Renaud S, de Lorgeril M (1992) Alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339:1523–1526
93. Artaud-Wild SM, Connor SL, Sexton G et al (1993) Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland. A paradox. Circulation 88:2771–2779
94. Pearson TA, Terry P (1994) What to advise patients about drinking alcohol: The clinician‘s conundrum. JAMA 272:967–968
95. Friedman GD, Klatsky AL (1993) Is alcohol good for your health? N Engl J Med 329:1882–1883
96. Gaziano JM, Buring JE, Breslow JL et al (1993) Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med 329:1829–1834
97. Ridker PM, Vaughan DE, Stampfer MJ et al (1994) Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA 272:929–933
98. Mennen LI, Balkau B, Vol S et al (1999) Fibrinogen: A possible link between alcohol consumption and cardiovascular disease? Arterioscler Thromb Vasc Biol 19:887–892
99. Renaud SC, Beswick AD, Fehily AM et al (1992) Alcohol and platelet aggregation: The Caerphilly Prospective Heart Disease study. Am J Clin Nutr 55(5):1012–1017
100. Pace-Asciak CR, Hahn S, Diamandis EP et al (1995) The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications for protection against coronary heart disease. Clin Chim Acta 235(2):207–219
101. Semba RD, Ferrucci L, Bartali B et al (2014) Resveratrol levels and all-cause mortality in older community-dwelling adults. JAMA Intern Med 174(7):1077–1084
102. Corder R, Douthwaite JA, Lees DM et al (2001) Entothelin-1 synthesis reduced by red wine. Nature 414(6866):863–864
103. Rosenkranz S, Knirel D, Dietrich H et al (2002) Inhibition of the PDGF receptor by red wine flavonoids provides a molecular explanation for the ”French paradox“. FASEB J 16(14):1958–1960
104. Strasser RH, Nuchter I, Rauch B et al (1996) Changes in cardiac sinal transduction systems in chronic ethanol treatment preceding the development of alcoholic cardiomyopathy. Herz 21:232–240
105. Ettinger PO, Wu CF, De La Cruz C, Weisse AB, Ahmed SS, Regan TJ (1978) Arryhthmias and the ”Holiday Heart“: Alcohol-associated cardiac rhythm disorders. Am Heart J 1978(95):555–562
106. Klatsky AL (2005) Alcohol and cardiovascular diseases: A historical review and 2005 update. http://www.aim-digest.com/gateway/pages/heart/articles/CVD/klatsky1105.htm. Accessed 8 Aug 2016
107. Patterson E, Dormer KJ, Scherlag BJ et al (1987) Long-term intracoronary ethanol administration electrophysiologic and morphologic effects. Alcohol 4:375–384
108. Greenspon AJ, Schaal SF (1983) The ”Holiday Heart“: Electrophysiologic studies of alcohol effects in alcoholics. Ann Intern Med 98:135–139
109. Kasper EK, Agema WR, Hutchins GM et al (1994) The causes of dilated cardiomyopathy: A clinicopathologic review of 673 consecutive patients. J Am Coll Cardiol 23:586–590
110. Johnson RA, Palacios I (1982) Dilated cardiomyopathies of the adult. N Engl J Med 307:1051–1058
111. Engler R, Ray R, Higgins CB (1982) Clinical assessment and follow-up of functional capacity in patients with chronic congestive cardiomyopathy. Am J Cardiol 1982(49):1832–1837
112. Follansbee WP, Michelson EL, Morganroth J (1980) Nonsustained ventricular tachycardia in ambulatory patients: Characteristics and association with sudden cardiac death. Ann Intern Med 92:741–747
113. Marriott HJL (1964) Electrocardiographic abnormalities, conduction disorders and arrhythmias in primary myocardial disease. Prog Cardiovasc Dis 7:99–114
114. Teragaki M, Takeuchi K, Takeda T (1993) Clinical and histologic features of alcohol drinkers with congestive heart failure. Am Heart J 125:808–817
115. Aretz HT, Billingham ME, Edwards WD et al (1987) Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol 1:3–14
116. Maisch B, Portic I, Ristic AD et al (2000) Definition of inflammatory cardiomyopathy (myocarditis): On the way to consensus. Herz 25(3):200–209
117. Maisch B, Bauer E, Hufnagel G (1988) The use of endomyocardial biopsies in heart failure. Eur Heart J 9(Suppl H):59–71
118. La Vecchia LL, Bedogni F, Bozzola L et al (1996) Prediction of recovery after abstinence in alcoholic cardiomyopathy: Role of hemodynamic and morphometric parameters. Clin Cardiol 19:45–50
119. Leggett BA, Powell LW, Halliday JW (1989) Laboratory markers of alcoholism. Dig Dis 7:125–134
120. Cohen JA, Kaplan MM (1979) The SGOT/SGPT ratio – an indicator of alcoholic liver disease. Dig Dis Sci 24:835–838
121. Williams AL, Hoofnagle JH (1988) Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis. Gastroenterology 95:734–739
122. Salaspuro M (1999) Carbohydrate-deficient transferrin as compared to other markers of alcoholism: A systemic review. Alcohol 19:261–271
123. Arndt T (2001) Carbohydrate-deficient transferrin as a marker of chronic alcohol abuse: A critical review of preanalysis, analysis, and interpretation. Clin Chem 47:13–27
124. Reynaud M, Schellenberg F, Loisequx-Meunier NN et al (2000) Objective diagnosis of alcohol abuse: Compared values of Carbohydrate-Deficient Transferrin (CDT), Gamma-Glutamyl Transferase (GGT), and Mean Corpuscular Volume (MCV). Alcohol Clin Exp Res 24:1414–1419
125. Mostofsky E, Chalhal HS, Mukamal KJ et al (2016) Alcohol and immediate risk of cardiovascular events: A systematic review and dose-response meta-analysis. Circulation 133(10):979–987
126. Nethala V, Brown EJ, Timson CR, Patcha R (1993) Reversal of alcoholic cardiomyopathy in a patient with severe coronary artery disease. Chest 104:626–632
127. Pathak SK, Kukreja RC, Hess M (1996) Molecular pathology of dilated cardiomyopathies. Curr Probl Cardiol 21:99–144
128. Guillo P, Mansourati J, Maheu B et al (1997) Long-term prognosis in patients with alcoholic cardiomyopathy and severe heart failure after total abstinence. Am J Cardiol 79:1276–1278
129. Prazak P, Pfisterer M, Osswald S et al (1996) Differences of disease progression in congestive heart failure due to alcoholic as compared to idiopathic dilated cardiomyopathy. Eur Heart J 17:251–257
130. Litten RZ, Allen JP (1998) Advances in development of medications for alcoholism treatment. Psychopharmacology (Berl) 139:20–33
131. Garbutt JC, West SL, Carey TS et al (1999) Pharmacological treatment of alcohol dependence: a review of the evidence. JAMA 281:1318–1325